Chemoinformaics analysis of 1,2-Dimethoxy-3,8-dihydroxyxanthone
Molecular Weight | 288.255 | nRot | 2 |
Heavy Atom Molecular Weight | 276.159 | nRig | 17 |
Exact Molecular Weight | 288.063 | nRing | 3 |
Solubility: LogS | -3.236 | nHRing | 1 |
Solubility: LogP | 2.693 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
nHA | 6 | APOL | 37.8635 |
nHD | 2 | BPOL | 18.1145 |
QED | 0.704 |
Synth | 2.498 |
Natural Product Likeliness | 1.551 |
NR-PPAR-gamma | 0.958 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.673 |
Pgp-sub | 0.003 |
HIA | 0.027 |
CACO-2 | -4.884 |
MDCK | 0.0000179 |
BBB | 0.019 |
PPB | 0.907023 |
VDSS | 0.812 |
FU | 0.159736 |
CYP1A2-inh | 0.946 |
CYP1A2-sub | 0.963 |
CYP2c19-inh | 0.293 |
CYP2c19-sub | 0.128 |
CYP2c9-inh | 0.697 |
CYP2c9-sub | 0.909 |
CYP2d6-inh | 0.664 |
CYP2d6-sub | 0.565 |
CYP3a4-inh | 0.412 |
CYP3a4-sub | 0.204 |
CL | 2.389 |
T12 | 0.67 |
hERG | 0.039 |
Ames | 0.668 |
ROA | 0.205 |
SkinSen | 0.806 |
Carcinogencity | 0.065 |
EI | 0.974 |
Respiratory | 0.148 |
NR-Aromatase | 0.765 |
Antiviral | Yes |
Prediction | 0.690394 |